Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit Anti-NMDA NR2B Subunit Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein from the C-terminal region of the NR2B subunit |
Rabbit Polyclonal Anti-NOTCH2 (Cleaved-Ala1734) Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-NOTCH2 (Cleaved-Ala1734) Antibody: A synthesized peptide derived from human NOTCH2 (Cleaved-Ala1734) |
Rabbit polyclonal Syndecan4 (Ab-179) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Syndecan4 around the phosphorylation site of serine 179 (E-G-SP-Y-D). |
Rabbit polyclonal IL1R Antibody (C-term E487)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IL1R antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-503 amino acids from the C-terminal region of human IL1R. |
Rabbit Polyclonal CD44 (Ser706) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD44 around the phosphorylation site of Serine 706 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against TRPM8 (Center R536)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This TRPM8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 521-552 amino acids from the Central region of human TRPM8. |
Rabbit polyclonal anti-OR10H1 antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human OR10H1. |
Rabbit polyclonal anti-NDUFA4L2 antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human NDUFA4L2. |
Rabbit Polyclonal Trk B (Tyr515) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Trk B around the phosphorylation site of Tyrosine 515 (peptide seq 509-521aa: VIENPQY(p)FGITN) |
| Modifications | Phospho-specific |
Anti-KLK5 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 279-293 amino acids of Human kallikrein-related peptidase 5 |
Anti-DIABLO Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 56-239 amino acids of human diablo, IAP-binding mitochondrial protein |
Rabbit Polyclonal Anti-CCR6 Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human CCR6 |
Rabbit Polyclonal Anti-CALCRL Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human CALCRL |
Rabbit Polyclonal Anti-NPHS2 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human NPHS2 |
Active filters
Applications
- WB
Antibody Hosts
- Rabbit
Clonalities
- Polyclonal
Conjugates
- Unconjugated
Families
- Transmembrane
Citations
- Yes
Availabilities
- In Stock
Filter by
Category
Target Symbol
- BAX (3)
- ABCC2 (1)
- ABCC3 (1)
- ANTXR1 (1)
- BCL2L10 (1)
- CALCRL (1)
- CCR6 (1)
- CD44 (1)
- CDH2 (1)
- CUX1 (1)
- CYP3A4 (1)
- DIABLO (1)
- ELOVL5 (1)
- ERBB2 (1)
- EXT1 (1)
- FFAR4 (1)
- FZD2 (1)
- GPD2 (1)
- GRIN2B (1)
- IL17RB (1)
- IL1R1 (1)
- ITGA4 (1)
- KDR (1)
- KLK5 (1)
- LILRB2 (1)
- MME (1)
- NDUFA4L2 (1)
- NOTCH2 (1)
- NPHS2 (1)
- NTRK2 (1)
- OPN3 (1)
- OR10H1 (1)
- PTPRJ (1)
- RHBDD2 (1)
- SCARB1 (1)
- SDC4 (1)
- SLC18A2 (1)
- SLC29A4 (1)
- SLC2A1 (1)
- SLC44A1 (1)
- TNFRSF10D (1)
- TNFRSF8 (1)
- TRPC6 (1)
- TRPM8 (1)
Reactivities
Modifications
Pathways
- Cytokine-cytokine receptor interaction (6)
- Pathways in cancer (6)
- Apoptosis (5)
- Huntington's disease (5)
- Amyotrophic lateral sclerosis (ALS) (4)
- Colorectal cancer (4)
- Hematopoietic cell lineage (4)
- Neurotrophin signaling pathway (4)
- Alzheimer's disease (3)
- Cell adhesion molecules (CAMs) (3)
- ECM-receptor interaction (3)
- Focal adhesion (3)
- Metabolic pathways (3)
- Prion diseases (3)
- p53 signaling pathway (3)
- ABC transporters (2)
- Adherens junction (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- MAPK signaling pathway (2)
- Neuroactive ligand-receptor interaction (2)
- Parkinson's disease (2)
- Adipocytokine signaling pathway (1)
- Basal cell carcinoma (1)
- Biosynthesis of unsaturated fatty acids (1)
- Bladder cancer (1)
- Calcium signaling pathway (1)
- Chemokine signaling pathway (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- Drug metabolism - cytochrome P450 (1)
- Drug metabolism - other enzymes (1)
- Endocytosis (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Glycerophospholipid metabolism (1)
- Heparan sulfate biosynthesis (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Leukocyte transendothelial migration (1)
- Linoleic acid metabolism (1)
- Long-term potentiation (1)
- Melanogenesis (1)
- Metabolism of xenobiotics by cytochrome P450 (1)
- Natural killer cell mediated cytotoxicity (1)
- Non-small cell lung cancer (1)
- Notch signaling pathway (1)
- Olfactory transduction (1)
- Oxidative phosphorylation (1)
- Pancreatic cancer (1)
- Prostate cancer (1)
- Regulation of actin cytoskeleton (1)
- Renal cell carcinoma (1)
- Renin-angiotensin system (1)
- Retinol metabolism (1)
- Systemic lupus erythematosus (1)
- VEGF signaling pathway (1)
- Vascular smooth muscle contraction (1)
- Wnt signaling pathway (1)